Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

217 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
2024 CUA-KCRNC Expert Report: Management of non-clear cell renal cell carcinoma.
Graham J, Ahmad AE, Basappa NS, Bernhard JC, Bhindi B, Bossé D, Breau RH, Canil CM, Castonguay V, Finelli A, Heng DYC, Inman BA, Kollmannsberger C, Lalani AA, Lavallée LT, Msaouel P, Prendeville S, Soleimani M, Tanguay S, Wood L, Richard PO, Alimohamed N, Huynh M, Kassouf W, Noonan K, Power N. Graham J, et al. Among authors: heng dyc. Can Urol Assoc J. 2024 Nov;18(11):E371-E386. doi: 10.5489/cuaj.9041. Can Urol Assoc J. 2024. PMID: 39500366 Free PMC article. No abstract available.
Management of Advanced Kidney Cancer: Kidney Cancer Research Network of Canada (KCRNC) consensus update 2019.
Hotte SJ, Kapoor A, Basappa NS, Bjarnason G, Canil C, Conter HJ, Czaykowski P, Graham J, Gray S, Heng DYC, Karakiewicz PI, Kollmannsberger C, Lalani AA, North SA, Patenaude F, Soulières D, Violette P, Winquist E, Wood LA, Dudani S, Maloni R, Reaume MN; Kidney Cancer Research Network of Canada. Hotte SJ, et al. Among authors: heng dyc. Can Urol Assoc J. 2019 Oct;13(10):343-354. doi: 10.5489/cuaj.6256. Can Urol Assoc J. 2019. PMID: 31603413 Free PMC article. No abstract available.
Prognostic impact of paraneoplastic syndromes on patients with non-metastatic renal cell carcinoma undergoing surgery: Results from Canadian Kidney Cancer information system.
Sun R, Breau RH, Mallick R, Tanguay S, Pouliot F, Kapoor A, Lavallée LT, Finelli A, So AI, Rendon RA, Fairey AS, Lattouf JB, Kawakami J, Bhindi B, Basappa NS, Wood LA, Bjarnason GA, Heng DYC, Bansal RK. Sun R, et al. Among authors: heng dyc. Can Urol Assoc J. 2021 Apr;15(4):132-137. doi: 10.5489/cuaj.6833. Can Urol Assoc J. 2021. PMID: 33007184 Free PMC article.
Management of advanced kidney cancer: Kidney Cancer Research Network of Canada (KCRNC) consensus update 2021.
Canil C, Kapoor A, Basappa NS, Bjarnason G, Bossé D, Dudani S, Graham J, Gray S, Hansen AR, Heng DYC, Karakiewicz PI, Kollmannsberger C, Lalani AA, North SA, Patenaude F, Soulières D, Thana M, Winquist E, Wood LA, Reaume MN, Maloni R, Hotte SJ; Kidney Cancer Research Network of Canada. Canil C, et al. Among authors: heng dyc. Can Urol Assoc J. 2021 Apr;15(4):84-97. doi: 10.5489/cuaj.7245. Can Urol Assoc J. 2021. PMID: 33830005 Free PMC article. No abstract available.
Adjuvant therapy for renal cell carcinoma: 2023 Canadian Kidney Cancer Forum consensus statement.
Lalani AA, Kapoor A, Basappa NS, Bhindi B, Bjarnason GA, Bosse D, Breau RH, Canil CM, Cardenas LM, Castonguay V, Chavez-Munoz C, Chu W, Dudani S, Graham J, Heng DYC, Kollmannsberger C, Lattouf JB, Morgan S, Reaume MN, Richard PO, Swaminath A, Tanguay S, Wood LA, Lavallée LT. Lalani AA, et al. Among authors: heng dyc. Can Urol Assoc J. 2023 May;17(5):E154-E163. doi: 10.5489/cuaj.8381. Can Urol Assoc J. 2023. PMID: 37185210 Free PMC article.
First-line sunitinib or pazopanib in metastatic renal cell carcinoma: The Canadian experience.
Lalani AA, Li H, Heng DYC, Wood L, Kalirai A, Bjarnason GA, Sim HW, Kollmannsberger CK, Kapoor A, Hotte SJ, Vanhuyse M, Czaykowski P, Reaume MN, Soulieres D, Venner P, North S, Basappa NS. Lalani AA, et al. Among authors: heng dyc. Can Urol Assoc J. 2017 Mar-Apr;11(3-4):112-117. doi: 10.5489/cuaj.4398. Can Urol Assoc J. 2017. PMID: 28515811 Free PMC article.
Prioritizing systemic therapies for genitourinary malignancies: Canadian recommendations during the COVID-19 pandemic.
Lalani AA, Chi KN, Heng DYC, Kollmannsberger CK, Sridhar SS, Blais N, Canil C, Czaykowski P, Hotte SJ, Iqbal N, Soulières D, Bossé D, Alimohamed NS, Basappa NS, Mukherjee SD, Winquist E, Wood LA, North SA. Lalani AA, et al. Among authors: heng dyc. Can Urol Assoc J. 2020 May;14(5):E154-E158. doi: 10.5489/cuaj.6595. Epub 2020 Apr 5. Can Urol Assoc J. 2020. PMID: 32267828 Free PMC article. No abstract available.
Determining generalizability of the Canadian Kidney Cancer information system (CKCis) to the entire Canadian kidney cancer population.
Tajzler C, Tanguay S, Mallick R, Ahrens B, Ly TL, Breau RH, Basappa NS, Kapoor A, Heng DYC, Pouliot F, Finelli A, Lavallée LT, So AI, Drachenberg DE, Soulières D, Bjarnason GA, Richard PO, Maloni R, Power NE, Haan M, Wood LA. Tajzler C, et al. Among authors: heng dyc. Can Urol Assoc J. 2020 Oct;14(10):E499-E506. doi: 10.5489/cuaj.6716. Can Urol Assoc J. 2020. PMID: 33275557 Free PMC article.
217 results